NOT Open Access | Turning the tide: targeting PfCRT to combat drug-resistant P. falciparum
Resistance to the current first-line antimalarials threatens the control of malaria caused by the protozoan parasite Plasmodium falciparum and underscores the urgent need for new drugs with novel modes of action.